Structural alterations of the EGFR gene in glioblastoma samples as a prognostic factor and molecular target for therapy
Introduction. Epidermal growth factor receptor (EGFR) is a transmembrane protein of the receptor tyrosine kinase family that is activated in various cancers (non-small cell lung cancer, colorectal cancer, head and neck tumors). In glial brain tumors, increased EGFR expression levels are characterist...
Saved in:
| Main Authors: | V. O. Varachev, O. Yu. Susova, A. A. Mitrofanov, G. S. Krasnov, D. R. Naskhletashvili, Yu. I. Ammour, S. D. Bezhanova, N. V. Sevyan, E. V. Prozorenko, A. Kh. Bekyashev, T. V. Nasedkina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-10-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/709 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLUT1 sensitizes tumor cells to EGFR-TKIs by binding with activated EGFR and regulating its downstream signaling pathways
by: Zhangrong Xie, et al.
Published: (2025-05-01) -
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide
by: Paolo Tini, et al.
Published: (2025-07-01) -
Efficiency of two available kits for amplification of three EGFR SNPs in patients with NSCLC: 181946 G/A (rs2293347), -191 C/A (rs712830) and -216G/T (rs712829) with GC-rich regions
by: V. Jurišić, et al.
Published: (2025-04-01) -
Integrating experimental and network pharmacology to explore the pharmacological mechanisms of Dioscin against glioblastoma
by: Huang Jianhui, et al.
Published: (2025-05-01) -
The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma
by: A. V. Kaminskiy, et al.
Published: (2023-06-01)